numares Targets 2018 For Metabolomic Bladder Cancer Test
Executive Summary
German diagnostics firm numares AG is targeting 2018 for a launch of a bladder cancer test based on its metabolomic biomarker network technology. The company obtained promising results from a retrospective study indicating that evaluation of metabolomic biomarker networks can be used as a diagnostic for bladder cancer.